BLANTYRE (Reuters) – Cholera cases in Malawi have tripled and four more people have died, the Ministry of Health said on Monday, a month after the spread of the disease from Zambia was thought to have been contained.
Source: Reuters Medical News
Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict
(Reuters) – A federal judge in Delaware has overturned a jury’s verdict requiring Gilead Sciences Inc to pay a record $2.54 billion because its hepatitis C drugs Sovaldi and Harvoni infringed a patent held by rival Merck & Co Inc.
Source: Reuters Medical News
AstraZeneca's immunotherapy drug wins key lung cancer approval
LONDON (Reuters) – AstraZeneca’s immunotherapy drug Imfinzi has won crucial approval from U.S. regulators for use in lung cancer, opening up a multibillion-dollar market for a medicine that has so far lagged behind competitors.
Source: Reuters Medical News
AN ALTERNATIVE VIEW: A Week in the Worst Healthcare System
KevinMD.com: A week in the worst health care system in the world
Matthew Hahn, MD, writes in this article on KevinMD.com that, “… every day my staff and I struggled to find ways (and the extra time it requires) to get patients basic medications and testing despite an expanding system of insurance company prior authorization processes that make it harder and harder to do almost anything.”
The doctor has an interesting take on his daily fight to get patients the kind of care and treatment they need. Read on at: KevinMD.com, A week in the worst health care system in the world
U.S. faces shortage of developmental and behavioral pediatrics specialists
(Reuters Health) – A shortage of clinicians specializing in pediatric behavioral and developmental disorders is translating into long wait times for new patient appointments amid surging demand, a new study suggests.
Source: Reuters Medical News
U.S. FDA approves AstraZeneca's immunotherapy for lung cancer
(Reuters) – The U.S. Food and Drug Administration on Friday granted approval for expanded use of AstraZeneca Plc’s, immunotherapy drug, Imfinzi, to treat non-small cell lung cancer whose tumors can’t be surgically removed.
Source: Reuters Medical News
Hospitalized older adults less often tested for flu
(Reuters Health) – Even though elderly people have the highest rates of hospitalization and death from influenza, a U.S. study suggests that older patients may be less likely to get tested for flu in the hospital.
Source: Reuters Medical News
Fear of federal law may prevent gun retailers from storing firearms
(Reuters Health) – What if someone who lived with the young man who unleashed one of the deadliest school shootings in U.S. history this week had been concerned that he might harm himself or others and removed his AR-15 rifle from his home?
Source: Reuters Medical News
In-person license renewal may reduce crashes involving people with dementia
Reuters Health – Older adults with dementia may be less likely to get in car crashes when they’re required to renew their driver’s licenses in person, a U.S. study suggests.
Source: Reuters Medical News
Novartis readies to auction U.S. generic pills business: sources
(Reuters) – Switzerland’s Novartis AG is preparing to auction its U.S. generic pill business, looking to shed a unit that has struggled amid fierce price competition, people familiar with the matter said on Friday.
Source: Reuters Medical News